2 December 2020 - Clinical stage immuno-oncology company Targovax ASA (OSE: TRVX), a developer of immune activators to target hard-to-treat solid tumours, declared on Tuesday that the combination of ONCOS-102 and pembrolizumab (Keytruda) has demonstr...
2 December 2020 - Biopharmaceutical company Ampio Pharmaceuticals Inc (NYSE American: AMPE) disclosed on Wednesday that its AP-014 Phase I inhaled Ampion clinical study in COVID-19 patients is proceeding to full open enrollment, having been cleared b...
2 December 2020 - Italy's Health Minister Roberto Speranza has stated that the country will launch a free coronavirus vaccination programme early in 2021, Reuters news agency reported on Wednesday.According to Speranza, the Italian government ha...
2 December 2020 - Biotechnology company Genentech reported on Tuesday the receipt of the US Food and Drug Administration's (FDA) supplemental Biologics License Application (sBLA) for Xolair (omalizumab) for the add-on maintenance treatment of na...
2 December 2020 - The drug regulator for the European Union has stated that its longer approval process for COVID-19 vaccines is safer, Reuters news agency reported on Wednesday.Emergency authorisation of Pfizer and BioNTech's COID-19 vaccine ha...